CTOs on the Move

SurgiMa

www.surgima.com

 
SurgiMa is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.surgima.com
  • 809 San Antonio Rd Ste 1
    Palo Alto, CA USA 94303
  • Phone: 650.494.0210

Executives

Name Title Contact Details

Similar Companies

Stewart Regional Blood Ctr

Stewart Regional Blood Ctr is a Tyler, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IlluminOss

IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, IlluminOss System. This minimally invasive technology allows for fracture fixation through patient specific intramedullary implants. The IlluminOss System utilizes a light-curable polymer, contained within an expandable balloon catheter to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of orthopedic bone stabilization. The company currently markets its products in the EU under a CE Mark for approved clinical applications through both a direct sales force and distribution networks. Founded in 2007, IlluminOss is headquartered in East Providence, RI, and funded by Flare Capital Partners, New Leaf Venture Partners, Tekla Capital, Life Sciences Partners, SR One, Longwood Fund, Excel Venture Management, Pappas Ventures, Mieza Capital and Slater Technology.

National Blood Ctr/S Florida Region

National Blood Ctr/S Florida Region is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.

OrbusNeich

OrbusNeich is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.